luf-5834 and regadenoson

luf-5834 has been researched along with regadenoson* in 1 studies

Other Studies

1 other study(ies) available for luf-5834 and regadenoson

Article	Year
A Structure (London, England : 1993), 2021, 02-04, Volume: 29, Issue:2 In drug design, G protein-coupled receptor (GPCR) partial agonists enable one to fine-tune receptor output between basal and maximal signaling levels. Here, we add to the structural basis for rationalizing and monitoring partial agonism. NMR spectroscopy of partial agonist complexes of the A Topics: Adenosine A2 Receptor Agonists; Aminopyridines; Binding Sites; Cell Line; Drug Partial Agonism; Humans; Imidazoles; Molecular Dynamics Simulation; Protein Binding; Purines; Pyrazoles; Receptor, Adenosine A2A	2021

Article

Year

Structure (London, England : 1993), 2021, 02-04, Volume: 29, Issue:2

In drug design, G protein-coupled receptor (GPCR) partial agonists enable one to fine-tune receptor output between basal and maximal signaling levels. Here, we add to the structural basis for rationalizing and monitoring partial agonism. NMR spectroscopy of partial agonist complexes of the A

Topics: Adenosine A2 Receptor Agonists; Aminopyridines; Binding Sites; Cell Line; Drug Partial Agonism; Humans; Imidazoles; Molecular Dynamics Simulation; Protein Binding; Purines; Pyrazoles; Receptor, Adenosine A2A

2021